Marina Capece
Biochemistry, Genetics and Molecular Biology · The Ohio State University
Publications
64
Citations
1,511
Est. group size
~14
Recurring co-author estimate
Active years
15
Publishing since 2012
Marina Capece's research focuses on how cancer cells interact with the immune system, with particular attention to the ATP receptor P2X7 and its role in tumor growth, as well as how cell senescence (a state where cells stop dividing) can be triggered by certain cancer drugs to make tumors more visible to the immune system. This work sits at the intersection of cell biology, cancer biology, and immunology, using mouse models and cell signaling pathways like cGAS-STING to study tumor-immune interactions.
Publication output was relatively steady at 3-4 items per year from 2018-2022, then spiked sharply in 2023 (largely due to supplementary materials from a small number of papers) before returning to a lower, steady level in 2024-2026.
Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026
- Abstract LB150: Senescence as an immune tolerance breaker: Inhibitors of mitotic kinases TTK (Mps1) and AURKA induce pro-immunogenic senescence that primes the tumor microenvironment for immunotherapy via cGAS-STING signaling
Cancer Research · 2026
- INTRAPLAQUE INJECTIONS OF HYALURONIC ACID IN PATIENTS SUFFERING FROM PEYRONIE’S DISEASE WITH VENTRAL CURVATURES
The Journal of Sexual Medicine · 2025
- Data from Accelerated Tumor Progression in Mice Lacking the ATP Receptor P2X7
2023
- Supplementary Figure 3 from Expression of P2X7 Receptor Increases <i>In Vivo</i> Tumor Growth
2023
- Supplementary Figure 2 from Expression of P2X7 Receptor Increases <i>In Vivo</i> Tumor Growth
2023
- Figure S2 from Accelerated Tumor Progression in Mice Lacking the ATP Receptor P2X7
2023
- Supplementary Figure 4 from Expression of P2X7 Receptor Increases <i>In Vivo</i> Tumor Growth
2023
- Supplementary Figure 1 from Expression of P2X7 Receptor Increases <i>In Vivo</i> Tumor Growth
2023
- Legends to Supplementary Figure from Accelerated Tumor Progression in Mice Lacking the ATP Receptor P2X7
2023
- Figure S1 from Accelerated Tumor Progression in Mice Lacking the ATP Receptor P2X7
2023
- Figure S3 from Accelerated Tumor Progression in Mice Lacking the ATP Receptor P2X7
2023
- SMovie S4 from Accelerated Tumor Progression in Mice Lacking the ATP Receptor P2X7
2023
- SMovie S5 from Accelerated Tumor Progression in Mice Lacking the ATP Receptor P2X7
2023
- Figure S3 from Accelerated Tumor Progression in Mice Lacking the ATP Receptor P2X7
2023
- SMovie S5 from Accelerated Tumor Progression in Mice Lacking the ATP Receptor P2X7
2023
- Cancer Research×9
- bioRxiv (Cold Spring Harbor Laboratory)×3
- Cell Death and Differentiation×2
- Signal Transduction and Targeted Therapy×2
- Nature Communications×2
- Mikhail M. Dikov
Biochemistry, Genetics and Molecular Biology · The Ohio State University
- Rachel A. Brown
Biochemistry, Genetics and Molecular Biology · The Ohio State University
- Fedias L. Christofi
Biochemistry, Genetics and Molecular Biology · The Ohio State University
- Kyle Gordon
Biochemistry, Genetics and Molecular Biology · The Ohio State University
- Ruohan Wu
Biochemistry, Genetics and Molecular Biology · The Ohio State University
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 19, 2026.
Claim or correct this profile